These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31661139)

  • 21. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
    Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
    Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.
    Wang L; Zhao Y; Wu Q; Guan Y; Wu X
    Mol Med Rep; 2018 Mar; 17(3):4299-4306. PubMed ID: 29363722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer.
    Chen R; Sheng C; Ma R; Zhang L; Yang L; Chen Y
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34523695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
    Xiong Y; Sun F; Dong P; Watari H; Yue J; Yu MF; Lan CY; Wang Y; Ma ZB
    J Exp Clin Cancer Res; 2017 Apr; 36(1):48. PubMed ID: 28399926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
    Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.
    Maney SK; McIlwain DR; Polz R; Pandyra AA; Sundaram B; Wolff D; Ohishi K; Maretzky T; Brooke MA; Evers A; Vasudevan AA; Aghaeepour N; Scheller J; Münk C; Häussinger D; Mak TW; Nolan GP; Kelsell DP; Blobel CP; Lang KS; Lang PA
    Sci Signal; 2015 Nov; 8(401):ra109. PubMed ID: 26535007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis.
    Li N; Piao J; Wang X; Kim KY; Bae JY; Ren X; Lin Z
    Cancer Res Treat; 2019 Oct; 51(4):1653-1665. PubMed ID: 31010277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
    Wang D; Wang H; Li Y; Li Q
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100A9 promotes the proliferation and migration of cervical cancer cells by inducing epithelial‑mesenchymal transition and activating the Wnt/β‑catenin pathway.
    Zha H; Li X; Sun H; Duan L; Yuan S; Li H; Li A; Gu Y; Zhao J; Xie J; Zhou L
    Int J Oncol; 2019 Jul; 55(1):35-44. PubMed ID: 31059008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
    Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
    Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
    Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
    Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.
    Ma D; Pan Z; Chang Q; Zhang JJ; Liu X; Hua N; Li GH
    BMC Cancer; 2021 Apr; 21(1):377. PubMed ID: 33827480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
    Zhao J; Li H; Yuan M
    Genes Genomics; 2021 May; 43(5):459-470. PubMed ID: 33687657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
    Wang J; Wang Y; Shen F; Xu Y; Zhang Y; Zou X; Zhou J; Chen Y
    Cancer Med; 2018 Nov; 7(11):5665-5678. PubMed ID: 30334367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway.
    Zhuang S; Yu X; Lu M; Li Y; Ding N; Ding Y
    J Gynecol Oncol; 2020 Nov; 31(6):e91. PubMed ID: 33078596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.